167 related articles for article (PubMed ID: 21525158)
1. Triglyceride response to an intensive lifestyle intervention is enhanced in carriers of the GCKR Pro446Leu polymorphism.
Pollin TI; Jablonski KA; McAteer JB; Saxena R; Kathiresan S; Kahn SE; Goldberg RB; Altshuler D; Florez JC;
J Clin Endocrinol Metab; 2011 Jul; 96(7):E1142-7. PubMed ID: 21525158
[TBL] [Abstract][Full Text] [Related]
2. The common P446L polymorphism in GCKR inversely modulates fasting glucose and triglyceride levels and reduces type 2 diabetes risk in the DESIR prospective general French population.
Vaxillaire M; Cavalcanti-Proença C; Dechaume A; Tichet J; Marre M; Balkau B; Froguel P;
Diabetes; 2008 Aug; 57(8):2253-7. PubMed ID: 18556336
[TBL] [Abstract][Full Text] [Related]
3. Lifestyle Intervention for Weight Loss and Cardiometabolic Changes in the Setting of Glucokinase Regulatory Protein Inhibition: Glucokinase Regulatory Protein-Leu446Pro Variant in Look AHEAD.
Belalcazar LM; Papandonatos GD; Erar B; Peter I; Alkofide H; Balasubramanyam A; Brautbar A; Kahn SE; Knowler WC; Ballantyne CM; McCaffery JM; Huggins GS;
Circ Cardiovasc Genet; 2016 Feb; 9(1):71-8. PubMed ID: 26578543
[TBL] [Abstract][Full Text] [Related]
4. Common missense variant in the glucokinase regulatory protein gene is associated with increased plasma triglyceride and C-reactive protein but lower fasting glucose concentrations.
Orho-Melander M; Melander O; Guiducci C; Perez-Martinez P; Corella D; Roos C; Tewhey R; Rieder MJ; Hall J; Abecasis G; Tai ES; Welch C; Arnett DK; Lyssenko V; Lindholm E; Saxena R; de Bakker PI; Burtt N; Voight BF; Hirschhorn JN; Tucker KL; Hedner T; Tuomi T; Isomaa B; Eriksson KF; Taskinen MR; Wahlstrand B; Hughes TE; Parnell LD; Lai CQ; Berglund G; Peltonen L; Vartiainen E; Jousilahti P; Havulinna AS; Salomaa V; Nilsson P; Groop L; Altshuler D; Ordovas JM; Kathiresan S
Diabetes; 2008 Nov; 57(11):3112-21. PubMed ID: 18678614
[TBL] [Abstract][Full Text] [Related]
5. The GCKR rs780094 polymorphism is associated with susceptibility of type 2 diabetes, reduced fasting plasma glucose levels, increased triglycerides levels and lower HOMA-IR in Japanese population.
Onuma H; Tabara Y; Kawamoto R; Shimizu I; Kawamura R; Takata Y; Nishida W; Ohashi J; Miki T; Kohara K; Makino H; Osawa H
J Hum Genet; 2010 Sep; 55(9):600-4. PubMed ID: 20574426
[TBL] [Abstract][Full Text] [Related]
6. Functional glucokinase regulator gene variants have inverse effects on triglyceride and glucose levels, and decrease the risk of obesity in children.
Horvatovich K; Bokor S; Polgar N; Kisfali P; Hadarits F; Jaromi L; Csongei V; Repasy J; Molnar D; Melegh B
Diabetes Metab; 2011 Nov; 37(5):432-9. PubMed ID: 21511510
[TBL] [Abstract][Full Text] [Related]
7. The GCKR-P446L gene variant predisposes to raised blood cholesterol and lower blood glucose in the P446L mouse-a model for GCKR rs1260326.
Ford BE; Chachra SS; Rodgers K; Moonira T; Al-Oanzi ZH; Anstee QM; Reeves HL; Schattenberg JM; Fairclough RJ; Smith DM; Tiniakos D; Agius L
Mol Metab; 2023 Jun; 72():101722. PubMed ID: 37031802
[TBL] [Abstract][Full Text] [Related]
8. GCKR variants increase triglycerides while protecting from insulin resistance in Chinese children.
Shen Y; Wu L; Xi B; Liu X; Zhao X; Cheng H; Hou D; Wang X; Mi J
PLoS One; 2013; 8(1):e55350. PubMed ID: 23383164
[TBL] [Abstract][Full Text] [Related]
9. Genotype effects of glucokinase regulator on lipid profiles and glycemic status are modified by circulating calcium levels: results from the Korean Genome and Epidemiology Study.
Kim OY; Kwak SY; Lim H; Shin MJ
Nutr Res; 2018 Dec; 60():96-105. PubMed ID: 30527264
[TBL] [Abstract][Full Text] [Related]
10. Association of GCKR rs780094, alone or in combination with GCK rs1799884, with type 2 diabetes and related traits in a Han Chinese population.
Qi Q; Wu Y; Li H; Loos RJ; Hu FB; Sun L; Lu L; Pan A; Liu C; Wu H; Chen L; Yu Z; Lin X
Diabetologia; 2009 May; 52(5):834-43. PubMed ID: 19241058
[TBL] [Abstract][Full Text] [Related]
11. Interaction effect of genetic polymorphisms in glucokinase (GCK) and glucokinase regulatory protein (GCKR) on metabolic traits in healthy Chinese adults and adolescents.
Tam CH; Ma RC; So WY; Wang Y; Lam VK; Germer S; Martin M; Chan JC; Ng MC
Diabetes; 2009 Mar; 58(3):765-9. PubMed ID: 19073768
[TBL] [Abstract][Full Text] [Related]
12. Early gene-diet interaction between glucokinase regulatory protein (GCKR) polymorphism, vegetable and fish intakes in modulating triglyceride levels in healthy adolescents.
Tam CH; Wang Y; Lee HM; Luk AO; Tong PC; Chan MH; Ozaki R; Kong AP; So WY; Chan JC; Ma RC
Nutr Metab Cardiovasc Dis; 2015 Oct; 25(10):951-8. PubMed ID: 26234566
[TBL] [Abstract][Full Text] [Related]
13. Effects of genetic variants previously associated with fasting glucose and insulin in the Diabetes Prevention Program.
Florez JC; Jablonski KA; McAteer JB; Franks PW; Mason CC; Mather K; Horton E; Goldberg R; Dabelea D; Kahn SE; Arakaki RF; Shuldiner AR; Knowler WC;
PLoS One; 2012; 7(9):e44424. PubMed ID: 22984506
[TBL] [Abstract][Full Text] [Related]
14. Glucokinase regulatory protein genetic variant interacts with omega-3 PUFA to influence insulin resistance and inflammation in metabolic syndrome.
Perez-Martinez P; Delgado-Lista J; Garcia-Rios A; Mc Monagle J; Gulseth HL; Ordovas JM; Shaw DI; Karlström B; Kiec-Wilk B; Blaak EE; Helal O; Malczewska-Malec M; Defoort C; Risérus U; Saris WH; Lovegrove JA; Drevon CA; Roche HM; Lopez-Miranda J
PLoS One; 2011; 6(6):e20555. PubMed ID: 21674002
[TBL] [Abstract][Full Text] [Related]
15. Associations of common polymorphisms in GCKR with type 2 diabetes and related traits in a Han Chinese population: a case-control study.
Ling Y; Li X; Gu Q; Chen H; Lu D; Gao X
BMC Med Genet; 2011 May; 12():66. PubMed ID: 21569451
[TBL] [Abstract][Full Text] [Related]
16. GCKR polymorphism influences liver fat content in patients with type 2 diabetes.
Petit JM; Masson D; Guiu B; Rollot F; Duvillard L; Bouillet B; Brindisi MC; Buffier P; Hillon P; Cercueil JP; Verges B
Acta Diabetol; 2016 Apr; 53(2):237-42. PubMed ID: 25976242
[TBL] [Abstract][Full Text] [Related]
17. Association of rs780094 in GCKR with metabolic traits and incident diabetes and cardiovascular disease: the ARIC Study.
Bi M; Kao WH; Boerwinkle E; Hoogeveen RC; Rasmussen-Torvik LJ; Astor BC; North KE; Coresh J; Köttgen A
PLoS One; 2010 Jul; 5(7):e11690. PubMed ID: 20661421
[TBL] [Abstract][Full Text] [Related]
18. The GCKR Gene Polymorphism rs780094 is a Risk Factor for Gestational Diabetes in a Brazilian Population.
Anghebem-Oliveira MI; Webber S; Alberton D; de Souza EM; Klassen G; Picheth G; Rego FG
J Clin Lab Anal; 2017 Mar; 31(2):. PubMed ID: 27554451
[TBL] [Abstract][Full Text] [Related]
19. Mendelian randomization studies do not support a role for raised circulating triglyceride levels influencing type 2 diabetes, glucose levels, or insulin resistance.
De Silva NM; Freathy RM; Palmer TM; Donnelly LA; Luan J; Gaunt T; Langenberg C; Weedon MN; Shields B; Knight BA; Ward KJ; Sandhu MS; Harbord RM; McCarthy MI; Smith GD; Ebrahim S; Hattersley AT; Wareham N; Lawlor DA; Morris AD; Palmer CN; Frayling TM
Diabetes; 2011 Mar; 60(3):1008-18. PubMed ID: 21282362
[TBL] [Abstract][Full Text] [Related]
20. The GCKR rs780094 polymorphism is associated with elevated fasting serum triacylglycerol, reduced fasting and OGTT-related insulinaemia, and reduced risk of type 2 diabetes.
Sparsø T; Andersen G; Nielsen T; Burgdorf KS; Gjesing AP; Nielsen AL; Albrechtsen A; Rasmussen SS; Jørgensen T; Borch-Johnsen K; Sandbaek A; Lauritzen T; Madsbad S; Hansen T; Pedersen O
Diabetologia; 2008 Jan; 51(1):70-5. PubMed ID: 18008060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
